Zota Health Care Limited (ZOTA.NS)
INR 770.0
(0.82%)
INR 770.0
(0.82%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -50.81 Million | -20.06 Million | 133.32 Million | -8.89 Million | 55.44 Million | -32.47 Million |
| Net Income | -143.47 Million | -46.91 Million | 124.34 Million | -3.65 Million | 38.61 Million | 78.55 Million |
| Depreciation & Amortization | 200.85 Million | 119.57 Million | 36.71 Million | 31.68 Million | 20.97 Million | 13.94 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 3.48 Million | - | - | - | - | - |
| Change in working capital | -119.8 Million | -82.9 Million | 19.7 Million | -19.11 Million | 17.18 Million | -87.87 Million |
| Other non-cash items | 455.78 Million | -9.81 Million | -47.44 Million | -17.81 Million | -21.33 Million | -37.09 Million |
| Investing Cash Flow | -138.39 Million | 147.03 Million | -266.52 Million | 38.2 Million | -35.29 Million | 88.25 Million |
| Investments in PPE | -167.1 Million | -124.99 Million | -32.48 Million | -19.28 Million | -61.77 Million | -31.23 Million |
| Acquisitions | 1.01 Million | 11.37 Million | - | 10.84 Million | - | - |
| Investment purchases | - | -264.4 Million | -248.44 Million | -10.84 Million | - | - |
| Sales/Maturities of investments | 27.68 Million | 253.03 Million | - | 40.35 Million | 15.87 Million | 105.27 Million |
| Other Investing Activities | -1000.00 | 272.02 Million | 14.4 Million | 17.13 Million | 10.6 Million | 14.21 Million |
| Financing Cash Flow | 188.1 Million | -138.81 Million | 142.73 Million | -24.19 Million | -28.74 Million | -63.45 Million |
| Debt repayment | -146.76 Million | -17.19 Million | -11.4 Million | -498 Thousand | - | - |
| Dividends payments | -25.84 Million | -37.74 Million | -25.16 Million | -24.56 Million | -29.6 Million | -52.63 Million |
| Common Stock Repurchased | - | - | -175.59 Million | - | - | - |
| Common Stock Issuance | 260.85 Million | - | 187 Million | - | 1 Million | 82.46 Thousand |
| Other Financing Activities | -49 Million | -83.87 Million | 167.89 Million | 868 Thousand | -5.18 Million | -10.91 Million |
| Accounts receivables | -302.62 Million | -52.95 Million | -94.76 Million | 2.93 Million | -70.4 Million | 8.3 Million |
| Accounts payables | 379.93 Million | 215.95 Million | 49.77 Million | 6.78 Million | -11.77 Million | -2.99 Million |
| Inventory | -119.78 Million | -128.41 Million | -7.71 Million | -28.41 Million | 71.71 Million | -82.29 Million |
| Other working capital | -77.33 Million | -117.49 Million | 72.39 Million | -408 Thousand | 27.63 Million | -10.89 Million |
| Cash at beginning of period | 11.15 Million | 22.99 Million | 13.46 Million | 8.34 Million | 16.94 Million | 24.62 Million |
| Cash at end of period | 10.04 Million | 11.15 Million | 22.99 Million | 13.46 Million | 8.34 Million | 16.94 Million |
| Capital Expenditure | -167.1 Million | -124.99 Million | -32.48 Million | -19.28 Million | -61.77 Million | -31.23 Million |
| Effect of forex changes on cash | 4000.00 | -1000.00 | -5000.00 | -4000.00 | - | 495.00 |
| Net cash flow / Change in cash | -1.1 Million | -11.84 Million | 9.52 Million | 5.11 Million | -8.59 Million | -7.67 Million |
| Free Cash Flow | -217.91 Million | -145.05 Million | 100.84 Million | -28.17 Million | -6.33 Million | -63.7 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -127.23 Million | -69.17 Million | -143.47 Million | -29.38 Million | -16.54 Million | -28.37 Million |
| Depreciation & Amortization | - | - | 200.85 Million | 50.79 Million | 47.99 Million | 34.07 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 3.48 Million | 3.48 Million | - | - | - |
| Change in working capital | - | - | -119.8 Million | - | - | - |
| Other non-cash items | 127.23 Million | 65.69 Million | 455.78 Million | 29.38 Million | 16.54 Million | 28.37 Million |
| Investing Cash Flow | - | - | -138.39 Million | - | - | - |
| Investments in PPE | - | - | -167.1 Million | - | - | - |
| Acquisitions | - | - | 1.01 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 27.68 Million | - | - | - |
| Other Investing Activities | - | - | -1000.00 | - | - | - |
| Financing Cash Flow | - | - | 188.1 Million | - | - | - |
| Debt repayment | - | - | -146.76 Million | - | - | - |
| Dividends payments | - | - | -25.84 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 260.85 Million | - | - | - |
| Other Financing Activities | - | - | -49 Million | - | - | - |
| Accounts receivables | - | - | -302.62 Million | - | - | - |
| Accounts payables | - | - | 379.93 Million | - | - | - |
| Inventory | - | - | -119.78 Million | - | - | - |
| Other working capital | - | - | -77.33 Million | - | - | - |
| Cash at beginning of period | - | - | 11.15 Million | 18.14 Million | 11.15 Million | 11.15 Million |
| Cash at end of period | - | - | 10.04 Million | 119.72 Million | 18.14 Million | 79.3 Million |
| Capital Expenditure | - | - | -167.1 Million | - | - | - |
| Effect of forex changes on cash | - | - | 4000.00 | - | - | - |
| Net cash flow / Change in cash | - | - | -1.1 Million | 101.58 Million | 6.99 Million | 68.15 Million |
| Free Cash Flow | - | - | -217.91 Million | 101.58 Million | 95.98 Million | 68.15 Million |
NVVE
1858
HYT
EFF
5519
ALAR